FDA Inspection 1181103 — Bridgewest Perth Pharma Pty Ltd.
The FDA completed an inspection of Bridgewest Perth Pharma Pty Ltd. on Aug 23, 2022 in Perth. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Perth (Australia)